|
Apr 19 |
PDS Biotech Announces Participation in Noble Capital Markets Virtual Road Show Series...
Florham Park, NJ, April 19, 2021 (GLOBE... |
|
Mar 18 |
PDS Biotech Reports Financial Results for the Year Ended December 31, 2020 and Provides Business Update...
FLORHAM PARK, N.J., March 18, 2021 (GLOBE... |
|
Mar 17 |
PDS Biotech Announces Presentation and Panel Participation at the Benzinga Biotech Small Cap Conference...
Florham Park, NJ, March 17, 2021 - PDS... |
|
Mar 11 |
PDS Biotech Announces that its COVID-19 Vaccine Consortium Received a Commitment from The Ministry of Science, Technolog...
Development and commercialization of novel... |
|
Mar 08 |
PDS Biotechnology Announces Conference Call and Webcast for Fourth Quarter and Full Year 2020 Financial Results...
FLORHAM PARK, N.J., March 08, 2021 (GLOBE... |
|
Mar 03 |
PDS Biotech Announces Presentations in Upcoming Healthcare Investor Conferences...
FLORHAM PARK, N.J., March 03, 2021 (GLOBE... |
|
Feb 22 |
PDS Biotech and Farmacore Announce Blanver to Join Consortium to Commercialize Novel Versamune®-Based T-Cell Inducing C...
Brazilian-based Blanver brings depth of... |
|
Feb 03 |
PDS Biotech Announces Preliminary Efficacy Achievement in Phase 2 Combination Trial of PDS0101 Led by the National Cance...
Full enrollment triggered by observation of 3... |
|
Jan 14 |
PDS Biotech Releases White Paper Detailing the Potential of the Versamune® Platform in Overcoming a Major Limitation of...
Promotes in-vivo tumor-attacking killer T-cells to... |
|
Jan 06 |
PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)...
FLORHAM PARK, N.J., Jan. 06, 2021 (GLOBE... |
|
Jan 05 |
PDS Biotech Announces Participation in H.C. Wainwright BioConnect 2021 Virtual Conference...
FLORHAM PARK, N.J., Jan. 05, 2021 (GLOBE... |
